Published in Clin Exp Immunol on October 01, 1988
Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med (1992) 1.77
Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon. J Exp Med (1989) 1.16
Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology (1990) 1.08
Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis. Clin Exp Immunol (1990) 0.95
Cell-bound IgE and increased expression of Fc epsilon-receptors on dendritic cells in cutaneous infiltrates of mycosis fungoides. Clin Exp Immunol (1991) 0.76
Soluble CD23 levels are inversely associated with atopy and parasite-specific IgE levels but not with polyclonal IgE levels in people exposed to helminth infection. Int Arch Allergy Immunol (2013) 0.75
Dermatology. Postgrad Med J (1990) 0.75
Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci U S A (1981) 3.62
Epidermal Langerhans cells bear Fc and C3 receptors. Nature (1977) 3.21
New staining techniques for the Langerhans cell. Acta Derm Venereol (1977) 2.37
Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10. Cell (1981) 1.92
A new immunologic marker for human Langerhans cells. N Engl J Med (1981) 1.79
Fc receptors for IgE on human and rat eosinophils. J Immunol (1981) 1.63
Fc receptors for IgE on a subpopulation of human peripheral blood monocytes. J Immunol (1980) 1.59
The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res (1986) 1.44
T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study. J Invest Dermatol (1983) 1.23
The thymic differentiation markers T6 and M241 are two unusual MHC class I antigens. J Immunol (1983) 1.21
Functional study of a monoclonal antibody to IgE Fc receptor (Fc epsilon R2) of eosinophils, platelets, and macrophages. J Exp Med (1986) 1.05
Role of immunoglobulin E and immunoglobulin E receptors in bronchial asthma. J Allergy Clin Immunol (1981) 0.98
Human epidermal Langerhans cells internalize by receptor-mediated endocytosis T6 (CD1 "NA1/34") surface antigen. Birbeck granules are involved in the intracellular traffic of the T6 antigen. J Invest Dermatol (1987) 0.97
Demonstration of Fcgamma receptors on human basophil granulocytes. J Immunol (1979) 0.97
Further biochemical characterization of the human thymocyte differentiation antigen T6. J Immunol (1982) 0.96
Location of HLA-A,B,C antigens in dendritic cells of normal human skin: an immunoelectron microscopic study. J Invest Dermatol (1983) 0.87
The cross-reactivity of rat IgE and IgG with solubilized receptors of rat basophilic leukemia cells. Mol Immunol (1982) 0.86
A role for glycoprotein IIb-IIIa complex in the binding of IgE to human platelets and platelet IgE-dependent cytotoxic functions. Br J Haematol (1986) 0.84
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med (1999) 5.85
Human asymptomatic Ebola infection and strong inflammatory response. Lancet (2000) 5.20
Treatment of hepatic hydatid disease with mebedazole: preliminary results in four cases. Br Med J (1977) 3.10
Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol (2002) 2.79
Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni schistosomules. Nature (1975) 2.19
Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol (1983) 2.17
Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med (1994) 2.01
High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature (1994) 1.95
Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med (1992) 1.88
Role of IgE receptors in effector function of human eosinophils. J Immunol (1984) 1.87
Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med (2001) 1.79
Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology (1996) 1.73
Functional studies on lymphocytes in adult human bone marrow. II. Isolated surface IgM-positive cells. J Immunol (1979) 1.70
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology (1999) 1.68
Fc receptors for IgE on human and rat eosinophils. J Immunol (1981) 1.63
Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization. Am J Dis Child (1993) 1.61
Evidence for IgE-dependent cytotoxicity by rat eosinophils. J Immunol (1981) 1.61
Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology (2000) 1.60
AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy (2008) 1.59
Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans R Soc Trop Med Hyg (1985) 1.58
Function and regulation of Fc epsilon RI expression on monocytes from non-atopic donors. Clin Exp Allergy (1996) 1.50
Immunity to schistosomes: progress toward vaccine. Science (1987) 1.49
Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with the NF-kappaB pathway. Eur J Immunol (1999) 1.49
Molecular cloning of a protective antigen of schistosomes. Nature (1987) 1.49
Interaction between IgE complexes and macrophages in the rat: a new mechanism of macrophage activation. Eur J Immunol (1977) 1.48
Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol (1992) 1.47
The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res (1986) 1.44
Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine (1997) 1.44
Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol (1996) 1.40
Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol (2005) 1.40
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood (1994) 1.39
[Eosinophils and pathology of the digestive tract]. Gastroenterol Clin Biol (1990) 1.38
Eosinophil-dependent cytotoxicity in rat schistosomiasis. Involvement of IgG2a antibody and role of mast cells. Eur J Immunol (1978) 1.33
The receptor for IgE on blood platelets. Eur J Immunol (1986) 1.32
IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J Immunol (1993) 1.30
Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol (1988) 1.29
Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. Clin Exp Immunol (1984) 1.28
Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties. Protein Eng Des Sel (2010) 1.27
Cytophilic binding of IgE to the macrophage. I. Binding characteristics of IgE on the surface of macrophages in the rat. Cell Immunol (1979) 1.23
Phase I clinical and pharmacologic study of chronic oral administration of the farnesyl protein transferase inhibitor R115777 in advanced cancer. J Clin Oncol (2002) 1.22
Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes. J Exp Med (1999) 1.22
Skin disease-related T cells bind to endothelial selectins: expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding. Eur J Immunol (1994) 1.20
In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies. J Immunol (1982) 1.19
Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomula. J Immunol (1978) 1.19
Cytophilic IgE on human blood and tissue eosinophils: detection by flow microfluorometry. J Immunol (1985) 1.18
IL-4 production by human polymorphonuclear neutrophils. J Leukoc Biol (2000) 1.18
Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen. Br Med J (1973) 1.16
Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J Allergy Clin Immunol (1991) 1.15
Lymphocyte 5'-nucleotidase in primary hypogammaglobulinaemia and cord blood. Clin Exp Immunol (1980) 1.14
Immunity in human schistosomiasis mansoni: prevention by blocking antibodies of the expression of immunity in young children. Parasitology (1987) 1.14
Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J Clin Microbiol (1990) 1.14
An anti-idiotype vaccine against experimental schistosomiasis. Nature (1985) 1.13
Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor. J Exp Med (1990) 1.12
The human immune response to alpha-haemocyanin of Helix pomatia. Acta Med Scand (1973) 1.11
Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils. J Immunol (1986) 1.11
Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol (1978) 1.10
Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett (2000) 1.10
Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut (1995) 1.09
Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies. Eur J Immunol (1993) 1.09
IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura. J Thromb Haemost (2009) 1.08
Infection of mice lacking interleukin-7 (IL-7) reveals an unexpected role for IL-7 in the development of the parasite Schistosoma mansoni. Infect Immun (1999) 1.08
Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity. Biochimie (1988) 1.08
Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host. Infect Immun (1999) 1.08
Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology (1990) 1.08
Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies. J Exp Med (1986) 1.07
Isotypic restriction of the antibody response to human immunodeficiency virus. AIDS Res Hum Retroviruses (1988) 1.07
Is cytomegalovirus infection a major cause of T cell alterations after (autologous) bone-marrow transplantation? Lancet (1984) 1.07
Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation. J Exp Med (1993) 1.07
Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood (1993) 1.06
Mercuric chloride induced autoimmune disease in Brown-Norway rats: sequential search for anti-basement membrane antibodies and circulating immune complexes. Eur J Clin Invest (1982) 1.06
Effector mechanisms of immunity to schistosomes and their regulation. Immunol Rev (1982) 1.06
Schistosoma mansoni shares a protective carbohydrate epitope with keyhole limpet hemocyanin. J Exp Med (1987) 1.06
Chemotherapy of human hydatid disease with mebendazole. Follow-up of 16 cases. Acta Gastroenterol Belg (1981) 1.06
Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma. Eur J Immunol (1999) 1.05
Functional study of a monoclonal antibody to IgE Fc receptor (Fc epsilon R2) of eosinophils, platelets, and macrophages. J Exp Med (1986) 1.05
Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response. J Hepatol (1989) 1.04
Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics (1989) 1.03
Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood (1997) 1.03
IgE antibody in eosinophil- and macrophage-mediated in vitro killing of Dipetalonema viteae microfilariae. J Immunol (1981) 1.03
Specific leukotriene formation by purified human eosinophils and neutrophils. FEBS Lett (1984) 1.03
Malaria co-infection in children influences antibody response to schistosome antigens and inflammatory markers associated with morbidity. Trans R Soc Trop Med Hyg (2004) 1.03
Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test. J Clin Microbiol (1992) 1.01
Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan. FEBS Lett (1985) 1.01
Blocking activity of rat monoclonal antibodies in experimental schistosomiasis. J Immunol (1984) 1.00
The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen. Clin Exp Immunol (1989) 1.00
Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur J Immunol (1997) 1.00
Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation. J Immunol (2001) 1.00
Antibody-dependent cell-mediated cytotoxicity against parasites. Prog Allergy (1982) 1.00
Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma. Thorax (1977) 0.99
Mechanisms of resistance to S. mansoni infection: the rat model. Parasitol Int (2000) 0.99
Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp Hematol (1998) 0.99
The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ. Eur Urol (2002) 0.99
Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis. Br J Dermatol (1988) 0.98
Eosinophils, allergy and parasites. Curr Opin Immunol (2001) 0.98
Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes. J Immunol (1987) 0.98
Circulating antigens and immune complexes in Schistosoma mansoni-infected rats. Characterization by radioimmunoprecipitation-PEG assay (RIPEGA). Clin Exp Immunol (1978) 0.98